ReviewNutrients2026
When Genetics Meets the Mediterranean Diet Across Metabolic Diseases.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic diseases and related cardiometabolic conditions, including type 2 diabetes (T2D), obesity, metabolic syndrome (MetS), and metabolic dysfunction-associated steatotic liver disease (MASLD), arise from complex interactions between genetic predisposition and environmental factors. Among dietary patterns, the Mediterranean diet (MedDiet) has consistently been associated with improved metabolic health and a reduced risk of cardiometabolic diseases. However, substantial interindividual variability in metabolic responses to dietary exposures suggests that genetic susceptibility may contribute to differences in response to the MedDiet. Over the past two decades, nutrigenetic research has investigated whether adherence to the MedDiet can modify the effects of genetic variants associated with metabolic risk. Initial studies focused primarily on candidate genes involved in glucose metabolism, adiposity regulation, circadian rhythms, and hepatic lipid metabolism, including variants in genes such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.